Last $8.92 USD
Change Today -0.30 / -3.25%
Volume 1.1M
IMGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:09 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Craig Barrows

Vice President, General Counsel and Secretary, ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

59--
As of Fiscal Year 2012

Background*

Mr. Craig Barrows has been Vice President, Secretary and General Counsel of Immunogen, Inc. since October 2007. Mr. Barrows has an extensive experience as Chief Legal Officer of Publicly-Traded Companies. He served as a General Counsel of Mercury Systems, Inc. (Formerly, Mercury Computer Systems Inc.) since August 2005 until February 2008, and also served as its Vice President and Assistant Secretary. Mr. Barrows served as Vice President, General Counsel and Secretary ...

Read Full Background

Corporate Headquarters*

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-895-0600
Fax: 781-895-0611

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
The University of Chicago
LLB
Fordham University School of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $8.92 USD -0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Edwin Moses Ph.D.Chief Executive Officer and Director
Ablynx NV
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.